27536065 |
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
Ahmadipour, F,
Abbaspour Babaei, M,
Huri, HZ,
Kamalidehghan, B,
Saleem, M
|
Drug Des Devel Ther |
2016 |
20927104 |
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
Dewell, S,
Antonescu, CR,
Chen, Y,
Maki, RG,
Zhang, L,
Sawyers, CL,
Allis, CD,
Shamu, T,
Guo, X,
Fletcher, JA,
Zheng, D,
Chi, P,
Wongvipat, J
|
Nature |
2010 |
28192400 |
Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors
Akieda, Y,
Abe, R,
Obata, Y,
Nishida, T,
Esumi, H,
Fletcher, JA,
Takahashi, T,
Tsujimoto, M,
Horikawa, K
|
Oncogene |
2017 |
25239608 |
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients
Anjum, R,
Heinrich, MC,
Ketzer, J,
Bauer, S,
Zhu, M,
Zhou, T,
Serrano, C,
Song, Y,
Fletcher, JA,
Schrock, A,
Ning, Y,
Eilers, G,
Wardwell, S,
Gozgit, JM,
Kohlmann, A,
Garner, AP,
Rivera, VM,
Vodala, S,
Clackson, T,
Wang, F
|
Clin. Cancer Res. |
2014 |